- List
- By Topic
- On Map
- Search Details

Bronchitis, Chronic
Need help? See RSS Feeds
Choose a feed type:

Bronchitis, Chronic (181 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00846911 | Completed | AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs |
|
|
Observational |
|
Industry |
|
|
2672 | All | 35 Years and older (Adult, Senior) | NCT00846911 | 14689 AX0701 13598 13855 13856 13857 14008 14007 14009 |
April 2008 | April 2010 | April 2010 | February 19, 2009 | July 9, 2012 |
|
|||
2 | NCT00644449 | Completed | A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
551 | All | 35 Years and older (Adult, Senior) | NCT00644449 | A0661102 | January 2003 | March 2004 | March 26, 2008 | May 16, 2011 |
|
|||
3 | NCT00538148 | Completed | Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
668 | All | 45 Years and older (Adult, Senior) | NCT00538148 | HMR3647A_4014 | November 2002 | September 2004 | September 2004 | October 2, 2007 | February 17, 2012 | |||
4 | NCT00649831 | Completed | A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
250 | All | 36 Years to 74 Years (Adult, Senior) | NCT00649831 | A0661045 | October 2002 | June 2003 | April 1, 2008 | October 21, 2008 |
|
|||
5 | NCT00288223 | Terminated | Telithromycin in Acute Exacerbation of Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
54 | All | 35 Years and older (Adult, Senior) | NCT00288223 | HMR3647A_4022 | January 2006 | January 2007 | January 2007 | February 7, 2006 | December 9, 2009 |
|
||
6 | NCT02483637 | Active, not recruiting | Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
30 | All | 40 Years to 75 Years (Adult, Senior) | NCT02483637 | 012 | Feasibility | February 2016 | September 2019 | September 2019 | June 29, 2015 | October 12, 2017 |
|
|
7 | NCT00254566 | Completed Has Results |
A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
398 | All | 50 Years and older (Adult, Senior) | NCT00254566 | A0661147 | February 2006 | August 2008 | August 2008 | November 16, 2005 | November 11, 2009 | September 2, 2009 |
|
|
8 | NCT03251911 | Not yet recruiting | VX-770 for the Treatment of Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
1 | All | 18 Years and older (Adult, Senior) | NCT03251911 | F160914011 | January 1, 2019 | January 1, 2020 | February 1, 2021 | August 16, 2017 | January 17, 2018 |
|
||
9 | NCT03107494 | Recruiting | Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
12 | All | 40 Years to 75 Years (Adult, Senior) | NCT03107494 | CS002 | January 20, 2017 | June 30, 2018 | June 30, 2019 | April 11, 2017 | November 6, 2017 |
|
||
10 | NCT00205647 | Completed | Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
240 | All | 18 Years to 75 Years (Adult, Senior) | NCT00205647 | ZAM-13343 | January 1997 | March 2000 | September 20, 2005 | November 6, 2017 |
|
|||
11 | NCT00269932 | Completed | A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
485 | All | 18 Years and older (Adult, Senior) | NCT00269932 | CR005497 | August 1993 | May 1994 | December 26, 2005 | June 10, 2011 | ||||
12 | NCT00257140 | Completed | A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria |
|
|
Interventional | Phase 2 Phase 3 |
|
Industry |
|
|
367 | All | 18 Years and older (Adult, Senior) | NCT00257140 | CR005494 | June 1931 | July 1994 | November 22, 2005 | June 10, 2011 | ||||
13 | NCT00656747 | Completed | Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
1372 | All | 60 Years and older (Adult, Senior) | NCT00656747 | 11980 2007-006096-37 |
March 2008 | December 2010 | December 2010 | April 11, 2008 | December 1, 2014 |
|
||
14 | NCT00473460 | Completed | Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
1404 | All | 45 Years to 90 Years (Adult, Senior) | NCT00473460 | 11229 EudraCT No: 2004-000404-40 |
October 2004 | January 2007 | January 2007 | May 15, 2007 | October 28, 2014 |
|
||
15 | NCT02515799 | Completed | Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Industry / Other |
|
|
27 | All | 40 Years to 85 Years (Adult, Senior) | NCT02515799 | 268/14 | Tacho-COPD | August 2014 | January 2015 | July 2015 | August 5, 2015 | August 5, 2015 |
|
|
16 | NCT03132610 | Recruiting | A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
240 | All | 18 Years to 75 Years (Adult, Senior) | NCT03132610 | JXQF-XYP-1608 | December 1, 2016 | December 1, 2017 | June 1, 2018 | April 28, 2017 | April 28, 2017 |
|
||
17 | NCT00255983 | Terminated | A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
491 | All | 35 Years and older (Adult, Senior) | NCT00255983 | REP-FAR-005 | December 2005 | May 2008 | June 2008 | November 21, 2005 | June 3, 2008 |
|
||
18 | NCT01979926 | Completed | Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
102 | All | 20 Years to 75 Years (Adult, Senior) | NCT01979926 | PMK-N02RS1 | November 2013 | November 2013 | March 2014 | November 8, 2013 | May 30, 2014 |
|
||
19 | NCT00132938 | Completed | PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
5660 | All | 35 Years and older (Adult, Senior) | NCT00132938 | HMR3647A_4020 EudraCT # :2004-001412-30 |
January 2004 | May 2006 | May 2006 | August 22, 2005 | June 8, 2011 |
|
||
20 | NCT03385616 | Recruiting | Gala Treatment for Chronic Bronchitis in Canada |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
12 | All | 40 Years to 75 Years (Adult, Senior) | NCT03385616 | CS004 | August 24, 2017 | December 30, 2018 | July 30, 2019 | December 28, 2017 | December 28, 2017 |
|
||
21 | NCT00454675 | Completed | Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis |
|
Observational |
|
Other / Industry |
|
100 | All | 40 Years to 80 Years (Adult, Senior) | NCT00454675 | COPD-2006-01 | March 2007 | August 2008 | April 2, 2007 | August 15, 2008 |
|
||||||
22 | NCT01739790 | Terminated Has Results |
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
51 | All | 40 Years to 85 Years (Adult, Senior) | NCT01739790 | 1210M21542 | January 2013 | December 2015 | December 2015 | December 3, 2012 | September 13, 2017 | September 13, 2017 |
|
|
23 | NCT02416102 | Recruiting | Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 35 Years to 75 Years (Adult, Senior) | NCT02416102 | 20140722 | October 2015 | February 2019 | May 2019 | April 14, 2015 | February 7, 2018 |
|
||
24 | NCT00876577 | Completed | VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis |
|
|
Observational |
|
Industry |
|
|
1206 | All | 18 Years and older (Adult, Senior) | NCT00876577 | 14495 AX0810CN |
VICTOR | May 2009 | March 2011 | March 2011 | April 6, 2009 | September 10, 2012 |
|
||
25 | NCT00645086 | Completed | Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
465 | All | 40 Years and older (Adult, Senior) | NCT00645086 | M02-472 | December 2002 | April 2004 | March 27, 2008 | March 27, 2008 |
|
|||
26 | NCT01420445 | Completed | Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
118 | All | 18 Years and older (Adult, Senior) | NCT01420445 | YHD001-202 | September 2011 | May 2012 | May 2012 | August 19, 2011 | September 26, 2013 |
|
||
27 | NCT03489837 | Recruiting New |
Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
272 | All | 19 Years to 75 Years (Adult, Senior) | NCT03489837 | HOB-048 | January 2017 | January 2019 | January 2019 | April 6, 2018 | April 6, 2018 |
|
||
28 | NCT00342030 | Completed | Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans |
|
Observational |
|
NIH | 63257 | All | 45 Years to 74 Years (Adult, Senior) | NCT00342030 | 999903044 03-E-N044 |
November 1, 2002 | April 12, 2012 | June 21, 2006 | July 2, 2017 |
|
|||||||
29 | NCT00879008 | Completed | SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB) |
|
|
Observational |
|
Industry |
|
|
345 | All | 18 Years and older (Adult, Senior) | NCT00879008 | 12629 AX0710DE |
SYMPROVE III | December 2009 | August 2010 | August 2010 | April 9, 2009 | June 23, 2014 |
|
||
30 | NCT02157571 | Unknown † | A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Exacerbations of Chronic Bronchitis With Levofloxacin Hydrochloride Tablet as Active Control |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
360 | All | 18 Years to 70 Years (Adult, Senior) | NCT02157571 | Prulifloxacin AECB ZK-004 | June 2013 | June 2014 | September 2014 | June 6, 2014 | June 6, 2014 |
|
||
31 | NCT02128529 | Completed | Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
|
Observational |
|
Industry |
|
|
976 | All | 40 Years and older (Adult, Senior) | NCT02128529 | RO-2455-401-BE | October 2010 | April 2011 | April 2011 | May 1, 2014 | November 2, 2016 | |||||
32 | NCT00042718 | Completed | A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis. |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
659 | All | 18 Years and older (Adult, Senior) | NCT00042718 | CR002650 | November 2001 | August 2003 | August 7, 2002 | April 28, 2010 | ||||
33 | NCT03073798 | Completed Has Results |
The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis |
|
|
Interventional | Phase 4 |
|
Other |
|
|
12 | All | 40 Years and older (Adult, Senior) | NCT03073798 | NA_00078710 | March 18, 2013 | May 14, 2015 | May 14, 2015 | March 8, 2017 | July 27, 2017 | July 27, 2017 | ||
34 | NCT01792271 | Completed | Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
25 | All | 40 Years to 80 Years (Adult, Senior) | NCT01792271 | 12-2602 1P01HL108808-01A1 |
February 2013 | May 2016 | May 2016 | February 15, 2013 | June 23, 2017 |
|
||
35 | NCT02250027 | Completed | A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
156 | All | 19 Years to 80 Years (Adult, Senior) | NCT02250027 | HL_HL301_201 | HL301 | March 2014 | July 2014 | July 2014 | September 26, 2014 | September 26, 2014 |
|
|
36 | NCT00035828 | Completed | A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD |
|
|
Interventional | Phase 2 |
|
Industry |
|
150 | All | 50 Years and older (Adult, Senior) | NCT00035828 | ABX-0209 | December 2001 | December 2002 | May 7, 2002 | June 24, 2005 |
|
||||
37 | NCT00423137 | Completed | Effect of BIBW 2948 BS in COPD |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
48 | All | 40 Years to 70 Years (Adult, Senior) | NCT00423137 | 1219.5 2006-001975-40 |
January 2007 | July 2008 | January 18, 2007 | May 16, 2014 |
|
|||
38 | NCT00726479 | Withdrawn | Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
0 | All | 40 Years and older (Adult, Senior) | NCT00726479 | 1219.4 EUDRACT2007-003742-15 |
August 2008 | September 2008 | August 1, 2008 | March 27, 2014 |
|
|||
39 | NCT00338507 | Completed | Phase 2 Study - Erdosteine in Patients With CB/COPD |
|
|
Interventional | Phase 2 |
|
Industry |
|
400 | All | 40 Years and older (Adult, Senior) | NCT00338507 | ERD-CB-01-2005 | March 2006 | June 20, 2006 | December 6, 2007 |
|
|||||
40 | NCT01599884 | Unknown † | N-Acetylcysteine for Patients With COPD and ChronicBronchitis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
65 | All | 40 Years to 85 Years (Adult, Senior) | NCT01599884 | MVMREF-001 | June 2012 | May 2013 | August 2013 | May 16, 2012 | May 16, 2012 |
|
||
41 | NCT03400735 | Recruiting | Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
50 | All | 18 Years to 80 Years (Adult, Senior) | NCT03400735 | NEU-08.16 | November 1, 2017 | April 1, 2018 | August 1, 2018 | January 17, 2018 | January 17, 2018 |
|
||
42 | NCT02341183 | Withdrawn | Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects |
|
|
Interventional | Not Applicable |
|
Other |
|
|
0 | All | 40 Years to 80 Years (Adult, Senior) | NCT02341183 | Pro00057004 | tPAD | May 2016 | May 2016 | May 2016 | January 19, 2015 | June 23, 2017 |
|
|
43 | NCT00932802 | Completed | Greatest International Antiinfective Trial With Avelox |
|
|
Observational |
|
Industry |
|
|
50000 | All | 12 Years and older (Child, Adult, Senior) | NCT00932802 | 12219 AX0401 11828 12206 12214 12234 12213 12212 12216 12220 12217 12225 12223 12229 12221 12218 12222 12230 12211 12227 12228 12226 12235 12233 12224 12215 12231 12232 |
GIANT | February 2004 | November 2007 | November 2007 | July 3, 2009 | November 19, 2012 |
|
||
44 | NCT01467297 | Completed | Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) |
|
|
Interventional | Phase 4 |
|
Other |
|
|
40 | All | 40 Years to 75 Years (Adult, Senior) | NCT01467297 | SP1 2011-000531-88 |
January 2012 | June 2012 | June 2012 | November 8, 2011 | June 5, 2012 |
|
||
45 | NCT02125747 | Completed | Respiratory Therapy in COPD Exacerbations |
|
|
Interventional | Not Applicable |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Senior) | NCT02125747 | PSM/RHB/CR/05 | TRESEPOCAS | December 2011 | May 2012 | November 2012 | April 29, 2014 | January 12, 2017 |
|
|
46 | NCT00546676 | Completed | Ketek in CAP / AECB in Ambulatory Adult Patients |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
174 | All | 18 Years and older (Adult, Senior) | NCT00546676 | HMR3647A_4018 | May 2004 | December 2004 | October 19, 2007 | November 14, 2007 | ||||
47 | NCT02942134 | Not yet recruiting | Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome) |
|
Observational |
|
Other |
|
|
70 | All | 18 Years to 80 Years (Adult, Senior) | NCT02942134 | S-484/2016 | November 2016 | October 2017 | May 2018 | October 21, 2016 | October 21, 2016 | |||||
48 | NCT00245427 | Completed | Outcomes of Patients Not Responding to Antibiotics in the Community |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
200 | All | up to 95 Years (Child, Adult, Senior) | NCT00245427 | HMR3647A-6012 | December 2005 | March 2006 | October 28, 2005 | October 31, 2007 |
|
|||
49 | NCT00181207 | Unknown † | Airway Clearance for Prevention of COPD Exacerbation |
|
|
Interventional | Phase 4 |
|
Other / U.S. Fed / Industry |
|
|
50 | All | 45 Years to 85 Years (Adult, Senior) | NCT00181207 | NA_000202 18-P-92858/3-01 |
May 2004 | November 2012 | December 2012 | September 16, 2005 | March 30, 2012 |
|
||
50 | NCT01354938 | Completed Has Results |
Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis |
|
|
Observational |
|
Industry |
|
|
220 | All | 35 Years and older (Adult, Senior) | NCT01354938 | P12-822 | May 2011 | January 2012 | January 2012 | May 17, 2011 | February 6, 2013 | January 30, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.